Abstract
Presented here is the 5-year impact of a national antimicrobial resistance surveillance system in Ireland, which was introduced in accordance with the European Antimicrobial Resistance Surveillance System (EARSS). Participation in EARSS began in Ireland in 1999. Initially, 12 laboratories serving a mix of general and tertiary hospitals participated, but by 2003, participation had increased to 28 laboratories with a population coverage of 89%. During 1999–2003, 4,146 episodes of Staphylococcus aureus bacteraemia were reported, and methicillin resistance was detected in 1,709 (41.2%) of these isolates. Over the same period, 1,245 invasive (blood or cerebrospinal fluid) episodes of Streptococcus pneumoniae infection were reported, and 160 (12.9%) isolates were found to be non-susceptible to penicillin, with 23 (1.8%) demonstrating high-level penicillin resistance. By 2003, most Irish hospitals were participating in EARSS, which has been a catalyst for the development of a national antimicrobial resistance surveillance programme.
Similar content being viewed by others
References
O’Brien TF (1997) The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clin Infect Dis 24 (Suppl 1):2–8
The Copenhagen Recommendations (1998) Report from an Invitational European Union Conference on ‘The Microbial Threat’. Copenhagen, Denmark
Subgroup of the Scientific Advisory Committee of the NDSC on Antimicrobial Resistance (2001) A strategy for the control of antimicrobial resistance in Ireland (SARI). The National Disease Surveillance Centre, Dublin, Ireland, pp 9–10
Bronzwaer SLAM, Goettsch W, Olsson-Liljequist B, Wale MC, Vatopoulos AC, Sprenger MJ (1999) European Antimicrobial Resistance Surveillance System (EARSS): objectives and organisation. Eurosurveillance 4:41–44
National institute of Public Health and the Environment. EARSS Annual Report 2002. Chapter 4. Netherlands 2003. http://www.earss.rivm.nl/PAGINA/DOC/rep2002/annual-report-2002.pdf
Humphreys H, O’Flanagan D (2001) Surveillance of hospital-acquired infection in the Republic of Ireland; past, present and future. J Hosp Infect 49:69–73
Johnson Z, Fitzpatrick P, Hayes C, Sayers G, Pelly H, McDonnell B, Thornton L, Buttimer J (1997) National survey of MRSA: Ireland, 1995. J Hosp Infect 35:175–184
McDonald P, Mitchell E, Johnson H, Rossney A, Humphreys H, Glynn G, Burd M, Doyle D, Mc Donnell R (2003) MRSA bacteraemia: north/south study of MRSA in Ireland 1999. J Hosp Infect 52:288–291
Cosgrove SE, Sakoulas G, Perencevich EN, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59
Maugein J, Guillemot D, Dupont MJ, Fosse T, Laurans G, Roussel-Delvallez M, Thierry J, Vergnaud M, Weber M, Poirier B (2003) Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight counties. Clin Microbiol Infect 9:280–288
Goldsmith CE, Moore JE, Murphy PG (1997) Pneumococcal resistance in the UK. J Antimicrob Chemother 40 (Suppl A):11–18
Felmingham D, Gruneberg RN and the Alexander Project Group (2000) The Alexander Project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community acquired lower respiratory tract infection. J Antimicrob Chemother 45:191–203
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A, Active Bacterial Core Surveillance of the Emerging Infections Program Network (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746
Bennett D, Lennon B, Humphreys H, Cafferkey M (2003) Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland. J Clin Microbiol 41:3641–3648
Clarke P, Murchan S, Smyth EG, Humphreys H (2004) Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. Clin Microb Infect 10:657–659
Acknowledgements
We are grateful for the help and assistance of all EARSS participating laboratories without which this data could not be collected and analyzed
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murphy, O.M., Murchan, S., Whyte, D. et al. Impact of the European Antimicrobial Resistance Surveillance System on the development of a national programme to monitor resistance in Staphylococcus aureus and Streptococcus pneumoniae in Ireland, 1999–2003. Eur J Clin Microbiol Infect Dis 24, 480–483 (2005). https://doi.org/10.1007/s10096-005-1357-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-005-1357-z